J. abu-abeeleh, “SIMVASTATIN TREATMENT AMELIORATES DIABETIC TYPE 2 CONDITIONS THROUGH LOWERING THE CONCENTRATION OF PLASMA ICAM LEVELS”, ESJ, vol. 11, no. 24, Aug. 2015.